Frédéric Pendino

1.2k citations

25 papers · 961 indexed · h-index 18

Impact in

Hematology top 5%
- Acute Myeloid Leukemia Research
Molecular Biology top 10%
- Retinoids in leukemia and cellular processes
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques

Papers in ⓘ

Hematology 11
- Acute Myeloid Leukemia Research 11
Biochemistry 4
- Antioxidant Activity and Oxidative Stress 4

Co-authors: E. Segal (15 shared papers)Michel Lanotte (10 shared papers)Josette Hillion (7 shared papers)Charles Dudognon (6 shared papers)François Delhommeau (4 shared papers)Jan Erik Varhaug (3 shared papers)Éric Nguyen (6 shared papers)János Aradi (3 shared papers)
Journals: Oncogene (4 papers)Leukemia (3 papers)Molecular Cancer Therapeutics (2 papers)Oncotarget (2 papers)Blood (2 papers)
Partner nations: France Norway Hungary

In The Last Decade

Frédéric Pendino

25 papers receiving 949 citations

Peers

Countries citing papers authored by Frédéric Pendino

Since Specialization

Citations

This map shows the geographic impact of Frédéric Pendino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Pendino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Pendino more than expected).

Fields of papers citing papers by Frédéric Pendino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Pendino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Pendino. The network helps show where Frédéric Pendino may publish in the future.

Co-authors

The 25 scholars most cited alongside Frédéric Pendino, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frédéric Pendino Line = papers co-authored together Frédéric Pendino links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors Blood ·Elodie Pronier, Carole Almire, Hayat Mokrani, Aparna Vasanthakumar, Audrey Simon, Bárbara da Costa Reis Monte-Mór, Aline Massé, Jean‐Pierre Le Couedic, Frédéric Pendino, B. Carbonne, Jérôme Larghero, Jean‐Luc Ravanat, Nicole Casadevall, Olivier Bernard, Nathalie Droin, Éric Solary, Lucy A. Godley, William Vainchenker, Isabelle Plo, François Delhommeau	2011	133
2	Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths Journal of Cell Science ·Yingli Wu, Charles Dudognon, Éric Nguyen, Josette Hillion, Frédéric Pendino, Ilona Tárkányi, János Aradi, Michel Lanotte, Jian-Hua Tong, Guoqiang Chen, E. Segal	2006	98
3	Induction of apoptosis in human cells by RNAi-mediated knockdown of hARD1 and NATH, components of the protein N-α-acetyltransferase complex Oncogene ·Thomas Arnesen, Darina Gromyko, Frédéric Pendino, Anita Ryningen, Jan Erik Varhaug, J.R. Lillehaug	2006	85
4	Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation Proceedings of the National Academy of Sciences ·Frédéric Pendino, Maria Flexor, François Delhommeau, Dorothée Selimoglu‐Buet, Michel Lanotte, E. Segal	2001	73
5	Death receptor signaling regulatory function for telomerase: hTERT abolishes TRAIL-induced apoptosis, independently of telomere maintenance Oncogene ·Charles Dudognon, Frédéric Pendino, Josette Hillion, Anne Saumet, Michel Lanotte, E. Segal	2004	66
6	Telomeres and Telomerase: Pharmacological Targets for New Anticancer Strategies? Current Cancer Drug Targets ·Frédéric Pendino, Ilona Tárkányi, Charles Dudognon, Josette Hillion, Michele Lanotte, János Aradi, E. Segal	2006	58
7	LEDGF/p75 has increased expression in blasts from chemotherapy-resistant human acute myelogenic leukemia patients and protects leukemia cells from apoptosis in vitro Molecular Cancer ·Tien‐sheng Huang, Line M. Myklebust, E. Kjarland, Bjørn Tore Gjertsen, Frédéric Pendino, Øystein Bruserud, Stein Ove Døskeland, Johan R. Lillehaug	2007	56
8	Mitochondrial metabolism sustains CD8+ T cell migration for an efficient infiltration into solid tumors Nature Communications ·Luca Simula, Mattia Fumagalli, Lene Vimeux, Irena Rajnpreht, Philippe Icard, Gary Birsen, Dongjie An, Frédéric Pendino, Adrien Rouault, Nadège Bercovici, Diane Damotte, Audrey Mansuet‐Lupo, Marco Alifano, Marie‐Clotilde Alves‐Guerra, Emmanuel Donnadieu	2024	45
9	Functional involvement of RINF, retinoid-inducible nuclear factor (CXXC5), in normal and tumoral human myelopoiesis Blood ·Frédéric Pendino, Éric Nguyen, Inge Jonassen, Bjarte Dysvik, Abdulkader Azouz, Michel Lanotte, E. Segal, Johan R. Lillehaug	2009	40
10	Characterization of hARD2, a processed hARD1 gene duplicate, encoding a human protein N-α-acetyltransferase BMC Biochemistry ·Thomas Arnesen, Matthew J. Betts, Frédéric Pendino, David A. Liberles, Dave C. Anderson, J. Jaime, Xianguo Kong, Jan Erik Varhaug, Johan R. Lillehaug	2006	35
11	Retinoic acid receptor α and retinoid-X receptor-specific agonists synergistically target telomerase expression and induce tumor cell death Oncogene ·Frédéric Pendino, Charles Dudognon, François Delhommeau, Tewfik Sahraoui, Maria Flexor, Annelise Bennaceur‐Griscelli, Michel Lanotte, E. Segal	2003	32
12	RINF (CXXC5) is overexpressed in solid tumors and is an unfavorable prognostic factor in breast cancer Annals of Oncology ·Stian Knappskog, Line M. Myklebust, Christian Busch, Thomas A. Aloysius, Jan Erik Varhaug, Per Eystein Lønning, J.R. Lillehaug, Frédéric Pendino	2011	32
13	Orchestration of multiple arrays of signal cross-talk and combinatorial interactions for maturation and cell death: another vision of t(15;17) preleukemic blast and APL-cell maturation Oncogene ·G Benoît, Mathilde Roussel, Frédéric Pendino, E. Segal, Michel Lanotte	2001	31
14	Retinoid/arsenic combination therapy of promyelocytic leukemia: induction of telomerase-dependent cell death Leukemia ·Ilona Tárkányi, Charles Dudognon, Josette Hillion, Frédéric Pendino, Michele Lanotte, János Aradi, E. Segal	2005	28
15	Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis Cell Death and Disease ·Gro Gausdal, Anita Wergeland, Jørn Skavland, Éric Nguyen, Frédéric Pendino, N Rouhee, Emmet McCormack, Lars Herfindal, Rune Kleppe, U Havemann, Frank Schwede, Øystein Bruserud, Bjørn Tore Gjertsen, Michel Lanotte, E. Segal, Stein Ove Døskeland	2013	24
16	A novel mechanism of retinoic acid resistance in acute promyelocytic leukemia cells through a defective pathway in telomerase regulation Leukemia ·Frédéric Pendino, Tewfik Sahraoui, Michel Lanotte, E. Segal	2002	22
17	hTERT Promotes Imatinib Resistance in Chronic Myeloid Leukemia Cells: Therapeutic Implications Molecular Cancer Therapeutics ·Laure Deville, Josette Hillion, Frédéric Pendino, Mona Samy, Éric Nguyen, E. Segal	2011	19
18	CXXC5 (Retinoid-Inducible Nuclear Factor, RINF) is a Potential Therapeutic Target in High-Risk Human Acute Myeloid Leukemia Oncotarget ·Audrey Astori, Hanne Fredly, Thomas A. Aloysius, Lars Bullinger, Véronique Mansat‐De Mas, Pierre de la Grange, François Delhommeau, Karen Marie Hagen, Christian Récher, Isabelle Dusanter‐Fourt, Stian Knappskog, Johan R. Lillehaug, Frédéric Pendino, Øystein Bruserud	2013	17
19	FOXP1 regulates oxidative stress, SIRT1 expression, and resistance to chemotherapies in acute myeloid leukemia cells Blood Advances ·Françoise Levavasseur, Samia Oussous, Tuerdi Zubaidan, Olivier Kosmider, Frédéric Pendino, David Rombaut, Didier Bouscary, Michaëla Fontenay, Evelyne Lauret, Isabelle Dusanter‐Fourt	2023	14
20	Loss of the Malignant Phenotype of Human Neuroblastoma Cells by a Catalytically Inactive Dominant-Negative hTERT Mutant Molecular Cancer Therapeutics ·Mona Samy, Charles‐Henry Gattolliat, Frédéric Pendino, Josette Hillion, Éric Nguyen, Sophie Bombard, Sétha Douc‐Rasy, Jean Bénard, E. Segal	2012	13

About Frédéric Pendino

Frédéric Pendino is a scholar working on Hematology, Biochemistry, Molecular Biology, Physiology and Oncology, having authored 25 papers that have together received 961 indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (14 papers), Acute Myeloid Leukemia Research (11 papers), Telomeres, Telomerase, and Senescence (7 papers), Antioxidant Activity and Oxidative Stress (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Chemokine receptors and signaling (2 papers), Virus-based gene therapy research (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Hematology (191 citations), Molecular Biology (733 citations), Physiology (247 citations), Cancer Research (109 citations) and Oncology (191 citations). Frédéric Pendino has collaborated with scholars based in France, Norway and Hungary. Frequent co-authors include E. Segal, Michel Lanotte, Josette Hillion, Charles Dudognon, François Delhommeau, Jan Erik Varhaug, Éric Nguyen, János Aradi, Thomas Arnesen and J.R. Lillehaug. Their work appears in journals such as Oncogene, Leukemia, Molecular Cancer Therapeutics, Oncotarget and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact